EQRX INC (EQRX) Stock Price, Quote, News and Overview
NASDAQ:EQRX - Nasdaq - US26886C1071 - Common Stock - Currency: USD
EQRX Quote, Performance and Key Statistics
2.34
-0.05 (-2.09%)
The current stock price of EQRX is 2.34 USD. In the past month the price increased by 5.41%. In the past year, price decreased by -36.24%.
EQRX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About EQRX
Company Profile
EQRx, Inc. is a pharmaceutical company, which engages in developing and delivering innovative medicines to patients having chronic conditions. The company is headquartered in Cambridge, Massachusetts and currently employs 362 full-time employees. The company went IPO on 2021-04-09. The firm is engaged in developing medicines for some of the prevalent disease areas, including cancer and immune-inflammatory conditions. The firm brands include EQRx and Remaking Medicine. The firm's pipeline is comprised of approximately 10 programs, including both small molecules and biologics, with five clinical-stage programs, and several disclosed and undisclosed preclinical and drug engineering programs. Its clinical programs include Aumolertinib (EQ143), Lerociclib (EQ132), and Sugemalimab (EQ165). Aumolertinib (EQ143) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Lerociclib (EQ132) is a novel and oral small molecule cyclin-dependent kinase (CDK) 4/6 inhibitor. Sugemalimab (EQ165, also known as CS1001) is an anti-programmed cell death-ligand 1 (PD-L1) monoclonal antibody.
Company Info
EQRX INC
50 Hampshire Street
Cambridge MASSACHUSETTS US
Employees: 362
Company Website: https://www.eqrx.com/
Phone: 16173152255.0
EQRX INC / EQRX FAQ
What is the stock price of EQRX INC today?
The current stock price of EQRX is 2.34 USD. The price decreased by -2.09% in the last trading session.
What is the ticker symbol for EQRX INC stock?
The exchange symbol of EQRX INC is EQRX and it is listed on the Nasdaq exchange.
On which exchange is EQRX stock listed?
EQRX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for EQRX INC stock?
7 analysts have analysed EQRX and the average price target is 2.14 USD. This implies a price decrease of -8.46% is expected in the next year compared to the current price of 2.34. Check the EQRX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EQRX INC worth?
EQRX INC (EQRX) has a market capitalization of 1.26B USD. This makes EQRX a Small Cap stock.
How many employees does EQRX INC have?
EQRX INC (EQRX) currently has 362 employees.
What are the support and resistance levels for EQRX INC (EQRX) stock?
EQRX INC (EQRX) has a support level at 2.26 and a resistance level at 2.47. Check the full technical report for a detailed analysis of EQRX support and resistance levels.
Should I buy EQRX INC (EQRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EQRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EQRX, evaluating the profitability, health, valuation and growth aspects
- EQRX INC (EQRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EQRX INC (EQRX) Sales and EPS estimates to see what analysts future expectations are.
- EQRX INC (EQRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EQRX INC (EQRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- EQRX INC (EQRX) Stock Chart to make your own analysis
- EQRX INC (EQRX) Latest news and press-releases to stay up to date.
Does EQRX INC (EQRX) stock pay dividends?
EQRX does not pay a dividend.
What is the Price/Earnings (PE) ratio of EQRX INC (EQRX)?
EQRX INC (EQRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.55).
EQRX Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to EQRX. When comparing the yearly performance of all stocks, EQRX is a bad performer in the overall market: 74.99% of all stocks are doing better.
EQRX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to EQRX. No worries on liquidiy or solvency for EQRX as it has an excellent financial health rating, but there are worries on the profitability.
EQRX Financial Highlights
Over the last trailing twelve months EQRX reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS decreased by -62.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.04% | ||
| ROE | -21.05% | ||
| Debt/Equity | 0 |
EQRX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to EQRX. The Buy consensus is the average rating of analysts ratings from 7 analysts.